Literature DB >> 18478869

Long-term neurological conditions: management at the interface between neurology, rehabilitation and palliative care.

Lynne Turner-Stokes1, Nigel Sykes, Eli Silber.   

Abstract

Long-term neurological conditions (LTNCs) comprise a diverse set of conditions resulting from injury or disease of the nervous system that will affect an individual for life. Some 10 million people in the UK are living with a neurological condition which has a significant impact on their lives, and they make up 19% of hospital admissions. These guidelines build on the Quality Requirements in the National Service Framework for Long-term (Neurological) Conditions to explore the interaction between specialist neurology, rehabilitation and palliative care services, and how they may best work together to provide long-term support for people with LTNCs and the family members who care for them. The guidelines also provide some practical advice for other clinicians when caring for someone with an LTNC, and outline indications for specialist referral. This article provides a brief summary. Full details of the methods and literature evaluation, as well as tools for implementation, are available in the full guideline.

Entities:  

Mesh:

Year:  2008        PMID: 18478869      PMCID: PMC4953006          DOI: 10.7861/clinmedicine.8-2-186

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  17 in total

1.  The effect of CTAB, a cationic surfactant, on the absorption rate of [14C]tripalmitate from a test meal in the rat.

Authors:  B Isomaa; G Sjöblom
Journal:  Food Cosmet Toxicol       Date:  1975-10

2.  Palliative and end-of-life care in advanced Parkinson's disease and multiple sclerosis.

Authors:  Colin W Campbell; Edward J S Jones; Jane Merrills
Journal:  Clin Med (Lond)       Date:  2010-06       Impact factor: 2.659

Review 3.  The role of palliative care in patients with neurological diseases.

Authors:  Gian Domenico Borasio
Journal:  Nat Rev Neurol       Date:  2013-04-02       Impact factor: 42.937

Review 4.  Palliative care interventions for people with multiple sclerosis.

Authors:  Carolina Oc Latorraca; Ana Luiza C Martimbianco; Daniela V Pachito; Maria Regina Torloni; Rafael L Pacheco; Juliana Gomes Pereira; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2019-10-22

Review 5.  Neurorehabilitation: applied neuroplasticity.

Authors:  Fary Khan; Bhasker Amatya; Mary P Galea; Roman Gonzenbach; Jürg Kesselring
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

6.  The changing relationship between neurology and general practice in the UK.

Authors:  Paul Morrish
Journal:  Br J Gen Pract       Date:  2009-08       Impact factor: 5.386

7.  Embedded Palliative Care for Amyotrophic Lateral Sclerosis: A Pilot Program and Lessons Learned.

Authors:  Kelly Fahrner-Scott; Carly Zapata; David L O'Riordan; Eve Cohen; Laura Rosow; Steven Z Pantilat; Catherine Lomen-Hoerth; Kara E Bischoff
Journal:  Neurol Clin Pract       Date:  2022-02

8.  Rehabilitation pathways in adult brain tumor patients in the first 12 months of disease. A retrospective analysis of services utilization in 719 patients.

Authors:  Andrea Pace; Veronica Villani; Cristiano Parisi; Stefano Di Felice; Margaux Lamaro; Chiara Falcicchio; Alessandro Bonucci; Patrizia Pugliese; Anteo di Napoli; Domenico Di Lallo
Journal:  Support Care Cancer       Date:  2016-07-15       Impact factor: 3.603

Review 9.  Postacute Cognitive Rehabilitation for Adult Brain Tumor Patients.

Authors:  Christina Weyer-Jamora; Melissa S Brie; Tracy L Luks; Ellen M Smith; Shawn L Hervey-Jumper; Jennie W Taylor
Journal:  Neurosurgery       Date:  2021-11-18       Impact factor: 5.315

10.  Psychometric Properties of a Generic, Patient-Centred Palliative Care Outcome Measure of Symptom Burden for People with Progressive Long Term Neurological Conditions.

Authors:  Wei Gao; Vincent Crosby; Andrew Wilcock; Rachael Burman; Eli Silber; Nilay Hepgul; K Ray Chaudhuri; Irene J Higginson
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.